Skip to content
value.today

Fuji Pharma Co., Ltd. vs Johnson & Johnson

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Johnson & Johnson is the larger company by market value: $652.5 B against $363 M for Fuji Pharma Co., Ltd., 1797 times as much (market caps of Mar 8, 2026 for Fuji Pharma Co., Ltd. and Oct 29, 2026 for Johnson & Johnson). Fuji Pharma Co., Ltd.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
  • Johnson & Johnson had more revenue: $94.2 B in the year to December 2025 against $313 M for Fuji Pharma Co., Ltd. in the year to September 2020.
  • Johnson & Johnson earned more: net income of $26.8 B against $19 M for Fuji Pharma Co., Ltd.
  • Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against 6.1% for Fuji Pharma Co., Ltd.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

043851281702020202120222023202420252026Fuji Pharma Co., Ltd. 95Johnson & Johnson 170

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$24B$47B$71B$94B20182019202020212022202320242025Johnson & Johnson $94B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureFuji Pharma Co., Ltd.
4554.T
Johnson & Johnson
JNJ · #24 in the world
Profile
Country🇯🇵 Japan🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19651886
Size
Market cap$363 M*$652.5 B
Revenue$313 M$94.2 B
Net income$19 M$26.8 B▲ best
Employees—138,200
Valuation
P/E ratio—40.5×
Price to sales—6.6×
Price to book—8.0×
Free cash flow yield—3.0%
Altman Z-score zone——
Data as ofMarket cap Mar 2026Market cap Oct 2026

Questions and answers#

Which is bigger, Fuji Pharma Co., Ltd. or Johnson & Johnson?

Johnson & Johnson is the larger company by market value: $652.5 B against $363 M for Fuji Pharma Co., Ltd., 1797 times as much (market caps of Mar 8, 2026 for Fuji Pharma Co., Ltd. and Oct 29, 2026 for Johnson & Johnson). Fuji Pharma Co., Ltd.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Fuji Pharma Co., Ltd. or Johnson & Johnson?

Johnson & Johnson had more revenue: $94.2 B in the year to December 2025 against $313 M for Fuji Pharma Co., Ltd. in the year to September 2020. Johnson & Johnson earned more: net income of $26.8 B against $19 M for Fuji Pharma Co., Ltd.

Which is more profitable, Fuji Pharma Co., Ltd. or Johnson & Johnson?

Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against 6.1% for Fuji Pharma Co., Ltd.